Congratulations, Nate Holiday and Scott Dykstra on Space and Time's $20M raise! We're excited to partner with you on this mission to bring the immutability of blockchain to AI applications. Read more here: https://lnkd.in/gx_ga_3A
F-Prime Capital
Risikokapital- und Private-Equity-Gesellschaften
Cambridge, MA 20,024 followers
We create and invest in healthcare and technology companies that impact lives all over the world.
Über uns
Our roots are in one of America’s great entrepreneurial success stories. Fidelity Investments was founded in 1946 and grew from a single mutual fund into one of the largest asset management firms in the world, with over $2 trillion in assets under management. For the last forty years, our venture capital group has had the privilege of backing other great entrepreneurs as they built ground-breaking companies in technology and life sciences, including Atari, MCI, ROLM Corp., Alibaba, Ironwood Pharmaceuticals, and Ultragenyx. Today our funds are larger and more global, but our teams are still small and local. We stay true to our entrepreneurial roots. In the US and Europe, we are F-Prime Capital investing in healthcare (formerly Fidelity Biosciences) and in technology (formerly part of Devonshire Investors). In other geographies, our sister fund is called Eight Roads (formerly Fidelity Growth Partners), with investment teams in London, Shanghai, Beijing, Hong Kong, Tokyo, and Mumbai. Together we bring a world of insight, domain expertise and relationships to support our entrepreneurs. Without the pressure of fundraising from outside investors, we focus all of our time finding and helping great entrepreneurs build important companies.
- Website
-
http://fprimecapital.com/
External link for F-Prime Capital
- Industrie
- Risikokapital- und Private-Equity-Gesellschaften
- Größe des Unternehmens
- 11-50 Mitarbeiter
- Hauptsitz
- Cambridge, MA
- Typ
- In Privatbesitz
Standorte
-
Primäre
One Main Street
Cambridge, MA 02142, US
Employees at F-Prime Capital
Aktualisierungen
-
This summer, F-Prime welcomed a new group of interns and fellows to our Cambridge offices for our 2024 Summer Internship/Fellowship Program. Over the next couple of weeks, we’re excited to have them share some of their experiences during the last several months with us. First up is Marlíse Arellano Sutton, a Harvard Business School candidate from Austin, Texas. Q: How did you learn about F-Prime, and why did you decide to join as an MBA intern? A: I saw F-Prime present at a HBS Healthcare Club Event, during which the team could have easily glossed over the background on VC and spent more time on the firm. Instead, they took time out of their presentation to explain VC and its mechanics to the group. Many of my peers noted how grateful they were for this, because they are pivoting to VC and the background information was incredibly helpful. To me, it demonstrated F-Prime’s commitment to mentorship and education and pushed me to apply. I decided to join the team because, throughout the interview process and my internship, I felt the team was genuinely invested in my learning and growth. This value system permeates F-Prime, as they are focused on learning from one another and the rest of the healthcare sector. Q: What kind of work did you do at F-Prime? A: I had the opportunity to work with a portfolio company, complete a deep-dive on an area in healthcare I was passionate about, and support the deal process for potential investments. I learned from and enjoyed all of this work, but was particularly excited that I had the chance to share my deep dive into pediatric severe mental illness with the whole healthcare team in my final weeks at the firm. That discussion encapsulated the great experience I have had at F-Prime. Everyone here is a lifelong learner and approaches topics with “actionable curiosity” — asking deep questions and providing even deeper answers and suggestions, whether it is on a simple question or how to reshape the care system to better serve children experiencing mental health crisis. Q: What surprised you most about working in venture capital? A: Although this was not surprising to me, I loved the constant drive F-Prime had for solving healthcare’s toughest problems. I also appreciated the mission-driven aspect of the investment process, focusing on clinical outcomes as well as the ROI a company could provide. As someone who has now worked on the VC and hospital side of the table, I am excited to see VC firms like F-Prime pushing the innovation envelope in healthcare and working with hospitals, government, payors, and others to make the healthcare system better for everyone.
-
-
Congratulations to AviadoBio and Neumora for being named in Labiotech.eu‘s “10 neuroscience biotech companies you should know about” list! This list highlights the most promising small biotech companies that are tackling the formidable challenges of developing treatments for neurological diseases. Learn more: https://lnkd.in/ddA2m5GQ Stacie Weninger, Ph.D. │ Nihal Sinha, M.D. │ Martin Taylor, Ph.D. #healthcare #neuroscience #biotech
-
Congratulations to Kristina Saffran, Erin Parks, Ph.D., and the Equip team for being featured in Forbes as one of the 2024 Next Billion-Dollar Startups. The list annually showcases U.S.-based private companies on track to achieve a $1 billion valuation, highlighting their potential as the next major industry disruptors. See the full list here: https://lnkd.in/eADCXisD Additionally, Equip CEO and co-founder Kristina Saffran shared with Forbes how her own recovery from anorexia revealed a gap in effective eating disorder treatment, driving the formation of Equip and its growth to become the leading provider of accessible, evidence-based eating disorder care. Learn more: https://lnkd.in/g4CcY_8C Jon Lim │ Brett Cook #BillionDollarStartups #healthcare #eatingdisorders #startup
Next Billion-Dollar Startups 2024
social-www.forbes.com
-
F-Prime Capital reposted this
Do you think India will be swept up in the $100Bn global surge of anti-obesity drugs? Join us at #ScaleUpHealth2024 as we hear this expert panel discuss this very question and share their views. Keep all your questions ready. We have limited seats, so if you haven’t already registered your interest to attend, follow this link – https://lnkd.in/g47wdgSF 🔸 Vikrant Shrotriya, Managing Director & Corporate Vice President, Novo Nordisk India 🔸 Dr. Shashank Joshi, Endocrinologist & President of Indian Academy of Diabetes 🔸 Madan Somasundaram, Co-founder & CEO, sugar.fit 🔸 Carl Bradford Byers 🚑, Partner, F-Prime Capital Eight Roads, McKinsey India #healthcare #conference #antobesity #events #scaleup #founders #lifesciences #entrepreneurs
-
-
F-Prime Capital reposted this
What a heartwarming and inspiring night 🥹 Last night, I had the privilege of gathering with 12 extraordinary senior women leaders in Fintech and Finance, each at different stages of their careers and personal lives. We shared stories of cross-connections at PayPal, Visa, and Wells Fargo, the joys and challenges of new parenthood, raising video game-loving teenagers, navigating career transitions, and discovering fellow Portuguese speakers. I’m endlessly inspired by each of these incredible women who embrace courage and vulnerability, put themselves out there, and live by the “Just Do It” mentality. As we celebrate the Paris Olympics achieving gender parity, I’m filled with hope that we can one day reach the same milestone in Fintech and Finance. When we support and uplift each other, we all rise together. Thank you for sharing the beautiful night with me and Sarah Lamont! Camilla Matias at Brex Yi Liu at Gusto Jessica Chiu at Airwallex Laura Fragomeni at Block Daniela Barbosa at The Linux Foundation Trisha Kothari at Unit21 Arthi Rajan Makhija at Pinch AI Cristina Etcheberry at Toku Mary Dent at Klaros Group Reetika Grewal at Wells Fargo Priya Nanduri at Visa Sara Wardell-Smith at Axos Financial
-
-
Congratulations to Ray Smets and the entire Quantum Circuits, Inc. team on securing your Series B investment round. This investment will support Quantum Circuits as they revolutionize the quantum computing industry with their first-of-its-kind dual-rail qubit featuring built-in error detection. Their innovative approach enables the fidelity, speed, and scalability needed for commercially viable quantum computers. “We see many quantum companies taking different approaches to solving the error correction challenge with varying degrees of success,” said Stephen Knight, M.D., President and Senior Managing Partner at F-Prime Capital. “Quantum Circuits leverages the speed, flexibility, and scalability of this approach to build high-fidelity systems that have the potential to be best-in-class.” Learn more: https://lnkd.in/gTbHxQmP ARCH Venture Partners │ Sequoia Capital │ Hither Creek Ventures │ Canaan │ Fitz Gate Ventures │ IQT (In-Q-Tel) │ Osage University Partners (OUP) │ Connecticut Innovations │ Tao Capital │ Tribeca Venture Partners Stephen Knight, M.D. │ Robert Weisskoff, Ph.D. │ Mike Feng #computing #technology #innovation
Yale Spinout in Quantum Field Draws US Intelligence Agency Money
bloomberg.com
-
Congratulations to our portfolio companies 1upHealth, Inc., AvantStay, Capital Rx, ConnexPay, Embark Veterinary, and Vestwell on being named in the 2024 Inc. 5000 list: ▪️ 1upHealth - https://lnkd.in/emvPQuxx ▪️ AvantStay - https://lnkd.in/emC2Q87m ▪️ Capital Rx - https://lnkd.in/eAhJyiwc ▪️ ConnexPay - https://lnkd.in/eJJ2cGPy ▪️ Embark Veterinary - https://lnkd.in/eb_AfHVz ▪️ Vestwell - https://lnkd.in/efXginEc The 2024 Inc. 5000 list is an annual ranking by Inc. Magazine that highlights the fastest-growing private companies in the U.S., based on their revenue growth over the past three years. Learn more: https://lnkd.in/g6Yn3rnH Sean Breuner │ A. J. Loiacono │ Ben Peters │ Amish Desai │ Aaron Schumm David Jegen │ Carl Bradford Byers 🚑 │ Abdul Abdirahman │ Brett Cook │ Jay Farber │ Gaurav Tuli #Inc5000 #tech #healthcare
-
-
F-Prime Capital reposted this
Had lots of fun chatting with my partner David Jegen and my now 2x former colleague Zoey Tang on the Wharton Fintech podcast. We talked all things fintech: a ten-year lookback on where fintech has truly innovated, where fintech is now, and where it's going next. What else would you have added? And what should we touch on for our 2025 report? Thanks for having us Wharton Fintech ! Link to the full episode in the comments.
-
-
Congratulations to Daniel Swisher, Alan Watt, Ph.D., and the entire NodThera team on your recognition as a 2024 Fierce 15 biotech company. The Fierce 15 is a prestigious list of biotech companies breaking barriers and defining the future of the industry. Nodthera was highlighted for its unique approach to inflammatory-driven diseases, such as obesity and Parkinson’s disease, by targeting the NLRP3 inflammasome. See the link in the comments section to learn more. Alex Pasteur, Ph.D. │ Nihal Sinha, M.D. │ Martin Taylor, Ph.D. #Fierce15 #biotech #healthcare Fierce Biotech
-